Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 54151-54200 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT05010005
A Study of Ruxolitinib and Duvelisib in People With Lymphoma
PHASE1
Recruiting
70 participants
Started: Aug 12, 2021 · Completed: Aug 31, 2027
4 conditions
1 sponsor
9 locations
NCT05003986
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
PHASE2
Recruiting
67 participants
Started: Aug 12, 2021 · Completed: Apr 12, 2027
5 conditions
1 sponsor
46 locations
NCT04946370
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
PHASE1/PHASE2
Recruiting
76 participants
Started: Aug 12, 2021 · Completed: Dec 31, 2029
1 condition
3 sponsors
4 locations
NCT04579848
Methotrexate in Erosive Inflammatory Hand Osteoarthritis
PHASE4
Recruiting
163 participants
Started: Aug 12, 2021 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT04432116
Time and Virtual Reality in Schizophrenia and Bipolar Disorder
NA
Recruiting
120 participants
Started: Aug 12, 2021 · Completed: May 12, 2027
2 conditions
1 sponsor
1 location
NCT05027711
Magnetic Resonance-guided Adaptive Stereotactic Body Radiotherapy for Hepatic Metastases
PHASE2
Recruiting
90 participants
Started: Aug 12, 2021 · Completed: Jan 31, 2027
1 condition
1 sponsor
1 location
NCT04624230
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
PHASE3
Recruiting
120 participants
Started: Aug 12, 2021 · Completed: May 15, 2029
1 condition
1 sponsor
77 locations
NCT04822675
REvascularization and Valve Intervention for Ischemic Valve diseasE: REVIVE Trial
NA
Recruiting
80 participants
Started: Aug 12, 2021 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT06278337
X-linked Moesin Associated Immunodeficiency
N/A
Recruiting
16 participants
Started: Aug 12, 2021 · Completed: Jan 12, 2027
4 conditions
1 sponsor
10 locations
NCT04924075
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
PHASE2
Recruiting
322 participants
Started: Aug 12, 2021 · Completed: Jun 4, 2029
5 conditions
1 sponsor
83 locations
NCT04836117
Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study
NA
Recruiting
200 participants
Started: Aug 12, 2021 · Completed: Aug 12, 2025
1 condition
2 sponsors
1 location
NCT04868604
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
PHASE1/PHASE2
Recruiting
54 participants
Started: Aug 11, 2021 · Completed: Sep 30, 2026
1 condition
1 sponsor
6 locations
NCT06001580
A Phase I Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors
PHASE1
Recruiting
36 participants
Started: Aug 11, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04954664
Ridge Augmentation Using Allograft Particles Hydrated with or Without Recombinant Human Platelet-Derived Growth Factor
NA
Recruiting
44 participants
Started: Aug 11, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06692790
VEHICLE Registry: Venous Stenting for IIH in the MENA Region
N/A
Recruiting
150 participants
Started: Aug 11, 2021 · Completed: Nov 11, 2025
1 condition
1 sponsor
2 locations
NCT04629495
Rapamycin - Effects on Alzheimer's and Cognitive Health
PHASE2
Recruiting
40 participants
Started: Aug 11, 2021 · Completed: Mar 31, 2026
2 conditions
2 sponsors
1 location
NCT05046002
COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
N/A
Recruiting
400 participants
Started: Aug 11, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05704361
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
PHASE1
Recruiting
165 participants
Started: Aug 11, 2021 · Completed: Apr 28, 2027
1 condition
1 sponsor
32 locations
NCT05010031
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
PHASE2
Recruiting
29 participants
Started: Aug 11, 2021 · Completed: Aug 31, 2026
1 condition
1 sponsor
7 locations
NCT04961437
Impact of Dyspnea, Regional Lung Ventilation, and Diaphragmatic Function During de Novo Acute Respiratory Failure
N/A
Recruiting
120 participants
Started: Aug 11, 2021 · Completed: Sep 11, 2025
1 condition
1 sponsor
1 location
NCT04391465
Assessment of the Relationship Between Cerebral Blood Flow and Heart Rate
NA
Recruiting
20 participants
Started: Aug 11, 2021 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT05029583
Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)
NA
Recruiting
5,000 participants
Started: Aug 11, 2021 · Completed: Oct 5, 2025
2 conditions
1 sponsor
1 location
NCT04745195
Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium
N/A
Recruiting
42 participants
Started: Aug 11, 2021 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05147441
Obturator Cryoneurotomy for Hip Adductor Spasticity
N/A
Recruiting
20 participants
Started: Aug 10, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04925427
Reducing Opioid Mortality in Illinois
NA
Recruiting
1,500 participants
Started: Aug 10, 2021 · Completed: Aug 30, 2026
2 conditions
9 sponsors
5 locations
NCT04896801
MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days
NA
Recruiting
132 participants
Started: Aug 10, 2021 · Completed: Feb 28, 2030
1 condition
1 sponsor
1 location
NCT05852730
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
PHASE2
Recruiting
80 participants
Started: Aug 10, 2021 · Completed: Sep 30, 2026
3 conditions
2 sponsors
1 location
NCT06255600
High-definition Transcranial Direct Current Stimulation and Chlorella Pyrenoidosa to Reduce Cardiovascular Risk
NA
Recruiting
60 participants
Started: Aug 10, 2021 · Completed: Jun 28, 2024
2 conditions
2 sponsors
1 location
NCT04864886
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
N/A
Recruiting
300 participants
Started: Aug 10, 2021 · Completed: Jun 30, 2027
4 conditions
1 sponsor
1 location
NCT05005975
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
PHASE3
Recruiting
301 participants
Started: Aug 10, 2021 · Completed: Dec 31, 2027
2 conditions
1 sponsor
51 locations
NCT05011227
Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma
PHASE2
Recruiting
100 participants
Started: Aug 10, 2021 · Completed: Aug 10, 2025
1 condition
2 sponsors
7 locations
NCT04916132
Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
N/A
Recruiting
300 participants
Started: Aug 10, 2021 · Completed: Dec 31, 2043
7 conditions
18 sponsors
13 locations
NCT04897022
A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma
PHASE1
Recruiting
24 participants
Started: Aug 10, 2021 · Completed: Aug 31, 2026
1 condition
1 sponsor
7 locations
NCT05436223
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
PHASE2
Recruiting
100 participants
Started: Aug 9, 2021 · Completed: Aug 9, 2026
1 condition
2 sponsors
1 location
NCT05024344
ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy
NA
Recruiting
128 participants
Started: Aug 9, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05392881
Interstitial Lung Disease Research Unit Biobank
N/A
Recruiting
1,000 participants
Started: Aug 9, 2021 · Completed: Mar 1, 2032
5 conditions
1 sponsor
1 location
NCT05004116
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
PHASE1/PHASE2
Recruiting
77 participants
Started: Aug 9, 2021 · Completed: Aug 31, 2028
2 conditions
1 sponsor
1 location
NCT06008249
Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)
PHASE3
Recruiting
171 participants
Started: Aug 9, 2021 · Completed: Jun 30, 2026
1 condition
10 sponsors
13 locations
NCT05580107
MDPK67b in Patients With Prostate Cancer
PHASE1
Recruiting
15 participants
Started: Aug 9, 2021 · Completed: Jun 30, 2024
1 condition
3 sponsors
1 location
NCT04794075
Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer
NA
Recruiting
300 participants
Started: Aug 9, 2021 · Completed: Aug 31, 2027
1 condition
3 sponsors
9 locations
NCT06234995
Cortical Electrophysiology of Response Inhibition in Parkinson's Disease
PHASE4
Recruiting
80 participants
Started: Aug 9, 2021 · Completed: Jul 31, 2026
1 condition
2 sponsors
2 locations
NCT04845230
Fresh RX: NHS 2020
NA
Recruiting
750 participants
Started: Aug 9, 2021 · Completed: Sep 15, 2026
8 conditions
2 sponsors
1 location
NCT04386005
Continuous Glucose Monitoring in At-Risk Newborns
NA
Recruiting
100 participants
Started: Aug 9, 2021 · Completed: Jun 30, 2026
1 condition
3 sponsors
1 location
NCT04769947
Italian Treatment Free Remission Registry
N/A
Recruiting
800 participants
Started: Aug 9, 2021 · Completed: Feb 8, 2030
2 conditions
1 sponsor
1 location
NCT04550624
Pembrolizumab in Combination With Lenvatinib in Patients With Advanced Biliary Tract Carcinoma
PHASE2
Recruiting
40 participants
Started: Aug 9, 2021 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT04704661
Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial
PHASE1
Recruiting
51 participants
Started: Aug 9, 2021 · Completed: Mar 31, 2026
40 conditions
1 sponsor
23 locations
NCT05817617
Vitamin D and Head and Neck Cancer: Impact on Toxicity and Prognosis
N/A
Recruiting
953 participants
Started: Aug 8, 2021 · Completed: Aug 31, 2026
1 condition
1 sponsor
10 locations
NCT04939571
European Disease Registry on Retinopathy of Prematurity (ROP)
N/A
Recruiting
3,000 participants
Started: Aug 6, 2021 · Completed: Aug 31, 2039
1 condition
1 sponsor
59 locations
NCT04787042
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
PHASE1/PHASE2
Recruiting
316 participants
Started: Aug 6, 2021 · Completed: Dec 31, 2025
9 conditions
2 sponsors
6 locations
NCT04891198
ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors
PHASE2
Recruiting
126 participants
Started: Aug 6, 2021 · Completed: Apr 30, 2028
1 condition
1 sponsor
1 location
Previous
1
More pages
1081
1082
1083
1084
1085
1086
1087
More pages
1333
Next